These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19695452)

  • 1. Indications for implantable cardioverter-defibrillators based on evidence and judgment.
    Myerburg RJ; Reddy V; Castellanos A
    J Am Coll Cardiol; 2009 Aug; 54(9):747-63. PubMed ID: 19695452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and quality-of-life effects of implantable cardioverter-defibrillators.
    Groeneveld PW; Matta MA; Suh JJ; Heidenreich PA; Shea JA
    Am J Cardiol; 2006 Nov; 98(10):1409-15. PubMed ID: 17134641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
    Groeneveld PW
    LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high cost of implantable defibrillators.
    Hlatky MA; Mark DB
    Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
    J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: the Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study.
    Crossley G; Boyle A; Vitense H; Sherfesee L; Mead RH
    Am Heart J; 2008 Nov; 156(5):840-6. PubMed ID: 19061696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implantable cardioverter defibrillator: its history, current psychological impact and future.
    Matchett M; Sears SF; Hazelton G; Kirian K; Wilson E; Nekkanti R
    Expert Rev Med Devices; 2009 Jan; 6(1):43-50. PubMed ID: 19105779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators.
    Naehle CP; Strach K; Thomas D; Meyer C; Linhart M; Bitaraf S; Litt H; Schwab JO; Schild H; Sommer T
    J Am Coll Cardiol; 2009 Aug; 54(6):549-55. PubMed ID: 19643318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do endoscopy capsules interfere with implantable cardioverter-defibrillators?
    Bandorski D; Irnich W; Brück M; Kramer W; Jakobs R
    Endoscopy; 2009 May; 41(5):457-61. PubMed ID: 19353490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems.
    Biffi M; Ziacchi M; Bertini M; Sangiorgi D; Corsini D; Martignani C; Diemberger I; Boriani G
    Europace; 2008 Nov; 10(11):1288-95. PubMed ID: 18772164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
    Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL;
    Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule.
    Lim HS; Lip GY; Tse HF
    Europace; 2008 May; 10(5):536-9. PubMed ID: 18367548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator use and benefit in women.
    Lampert R
    Cardiol Rev; 2007; 15(6):298-303. PubMed ID: 18090065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification in surgically repaired tetralogy of Fallot.
    Khairy P; Dore A; Poirier N; Marcotte F; Ibrahim R; Mongeon FP; Mercier LA
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):755-62. PubMed ID: 19589112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does ICD indication affect quality of life and levels of distress?
    Pedersen SS; Sears SF; Burg MM; Van Den Broek KC
    Pacing Clin Electrophysiol; 2009 Feb; 32(2):153-6. PubMed ID: 19170902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First multi-centre evaluation of a knowledge-based implant-assistant for implantable cardioverter-defibrillators.
    Diem BH; Lang V; Sinha AM; Mlynski M; Stellbrink C; Ameling W; Hanrath P
    Europace; 2006 Mar; 8(3):161-7. PubMed ID: 16627432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial issues of patients with implantable cardioverter defibrillators.
    Dunbar SB
    Am J Crit Care; 2005 Jul; 14(4):294-303. PubMed ID: 15980420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the equivalence of some medical cost estimators with censored data.
    Zhao H; Bang H; Wang H; Pfeifer PE
    Stat Med; 2007 Oct; 26(24):4520-30. PubMed ID: 17380543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.